
Shares of DNA test provider Prenetics Global PRE.O rise 16.25% at $10.30 in early trading
Co increases FY2025 revenue outlook to $85 mln to $100 mln from previous forecast of $80 mln to $100 mln; aims for break-even in Q1 2026
Prenetics reports almost 600% quarterly revenue jump of $17.7 million compared to previous year, but below expectations of $21.70 million - data compiled by LSEG
As of last close, PRE up 52.76% YTD